β-Hydroxybutyrate alleviates intestinal aGVHD via remodeling gut microbiota-bile acid axis and inhibiting TLR4-NF-κB-driven Th1/Th17 differentiation

Life Sciences · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles